270. Chronic recurrent multifocal osteomyelitis Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 11 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 71
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Adalimumab
Seattle Children's Hospital
2018 - NCT04725422 United States
Certolizumab
Seattle Children's Hospital
2018 - NCT04725422 United States
Etanercept
Seattle Children's Hospital
2018 - NCT04725422 United States
Golimumab
Seattle Children's Hospital
2018 - NCT04725422 United States
Infliximab
Seattle Children's Hospital
2018 - NCT04725422 United States
Leflunomide
Seattle Children's Hospital
2018 - NCT04725422 United States
Methotrexate
Seattle Children's Hospital
2018 - NCT04725422 United States
Nsaid
Seattle Children's Hospital
2018 - NCT04725422 United States
Pamidronate
Seattle Children's Hospital
2018 - NCT04725422 United States
Sulfasalazine
Seattle Children's Hospital
2018 - NCT04725422 United States
Zoledronic acid
Seattle Children's Hospital
2018 - NCT04725422 United States
Seattle Children's Hospital
2018 - NCT04725422 United States
Certolizumab
Seattle Children's Hospital
2018 - NCT04725422 United States
Etanercept
Seattle Children's Hospital
2018 - NCT04725422 United States
Golimumab
Seattle Children's Hospital
2018 - NCT04725422 United States
Infliximab
Seattle Children's Hospital
2018 - NCT04725422 United States
Leflunomide
Seattle Children's Hospital
2018 - NCT04725422 United States
Methotrexate
Seattle Children's Hospital
2018 - NCT04725422 United States
Nsaid
Seattle Children's Hospital
2018 - NCT04725422 United States
Pamidronate
Seattle Children's Hospital
2018 - NCT04725422 United States
Sulfasalazine
Seattle Children's Hospital
2018 - NCT04725422 United States
Zoledronic acid
Seattle Children's Hospital
2018 - NCT04725422 United States